Teladoc’s (TDOC) recent second-quarter financial report reflects its difficulties gaining traction in the fiercely ...

Five years ago, the COVID-19 pandemic had not begun to wreak havoc in the world yet. Teladoc (NYSE: TDOC), a telemedicine specialist, was a little-known but rising star in its niche. The company's ...

Teladoc has fallen sharply in recent years. It's facing growing competition and isn't profitable. Some may see this as an opportunity, but tread carefully. We'll get to Teladoc's performance soon ...

Digital medical services platform Teladoc Health (NYSE:TDOC) will be announcing earnings results tomorrow after market hours. Here’s what investors should know. Teladoc missed analysts ...

Teladoc Health Integrated Care —its virtual care business aimed at health plans, employers and health systems—brought in $387.7 million in revenue, up 2.5% from 2023. Revenue was above the top ...

Digital health companies faced high advertising costs and focused on returns on investments in the third quarter.

Since inception, Teladoc has partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while ...

Goldman Sachs initiated coverage of Teladoc (TDOC) with a Buy rating and $14 price target The company’s integrated care business should generate continued membership and revenue growth ...